Social Media Ideas for Csnrx

<![CDATA[Roundup: CSL & Alentis Enter Global Partnership, Jiangsu Nhwa Enters Global Licensing Deal with Somniver...

Corvus Pharmaceuticals: Steady As She Goes With Strong Footing In Atopic Dermatitis Treatment

Nurix: Maintaining 'Strong Buy' Updated Bexobrutideg Data CLL/SLL And Multiple Advancement Pathways

<![CDATA[Pharmaceutical Executive Daily: CSL & Alentis Enter $1.6 Billion Global Partnership]]>

Cohen & Steers (CNS) Q3 2026 Earnings Call Transcript

Net inflows hit $1.6 billion as institutional pipeline surged to $1.9 billion.

DataMEDS AI Establishes "Health Lives Here" Community Respiratory Program for Corexa Health Pharmacy Network

Being marketed to 6,500+ Corexa Health Pharmacy Network of independent pharmaciesTo be launched first at Corexa Pharmacy in Lakeland, FL retail location in Q4/2026Program will aim...

PCN: A Rare Discount Creates A Much Better Entry Point

Cue Biopharma: Initiating 'Buy' Based On CUE-221 Trial Win CSU With Novel Dual MOA

Axsome rises on Auvelity prescription data

Csquare, Inc. Investigation Notice: Levi & Korsinsky Notifies Investors of Pending Investigation Into Csquare, Inc....

Of the $356.0 million in "available liquidity" Csquare reported for June 30, 2026, $209.5 million was restricted cash that its own filing described as unavailable for general corpo...

<![CDATA[Roundup: Nanexa, Earendil Labs, and Atavistik Bio Enter Platform Deals with Novo Nordisk, Genentech, and Roc...

Nektar Therapeutics (NKTR) Shareholder/Analyst Call - Slideshow

Surrozen, Inc. (SRZN) Presents at Morgan Stanley 24th Annual Global Healthcare Conference Transcript

Cencora Remains A Buy At These Prices, As Healthcare Supply-Chain Needs Grow

CSD: A Differentiated Satellite Position Built On Corporate Carve-Outs

Kiniksa Pharmaceuticals Has Strong Growth And Little Room For Disappointment

Centene: The Turnaround Has More Room To Run

Cosmos Health Reaches 6,287 Active U.S. Subscriptions, Substantially All Added Since Mid-September, with 60.5% of Online...

в—Џ 6,287 active U.S. subscriptions as of October 14, 2026, the vast majority added since mid-September as the Company accelerates investment in its U.S. platformв—Џ 60.5% of U.S....

NMCO's Rights Offering Results

Cosmos Health CEO Greg Siokas Issues Letter to Shareholders Highlighting Record 2026 Revenue, U.S. Subscription Growth a...

Key HighlightsRecord revenue: preliminary nine-month 2026 revenue of approximately $54.3 million, up 19%, with every quarter of 2026 setting a record2026 outlook reaffirmed: full-y...

Arcturus sees positive results from mid-stage trial of RCT-810 in OTC deficiency

NexTel Medical Corp. Announces Next-Generation Wellness Product Line Incorporating FDA-Approved Pharmaceuticals

Innovative Delivery Technologies Aimed at Enhancing Bioavailability and Expanding Patient Access Beyond Traditional Injections

<![CDATA[Roundup: TRexBio & Retension Pharmaceuticals Announce IPO Pricing ]]>

Dianthus gains new Buy from Citi on multi-blockbuster potential for lead drug